Division of Allergy Pulmonary and Critical Care Medicine

(iStock image)
December 16, 2024

VUMC awarded $26.4 million for patient-centered research

The awards support research efforts to identify optimal approaches to improving health care and health outcomes for patients, families and the community.

By Bill Snyder
(file photo by Anne Rayner)
December 5, 2024

VUMC to study effect of breathing tube size on breathing, speaking, swallowing

Approximately 1% of the U.S. population — 2 million to 3 million adults — experience critical illness requiring the placement of a breathing tube each year.

By Nancy Humphrey
(iStock)
November 14, 2024

Studies to explore molecular drivers of pulmonary diseases

Three grants, totaling over $22 million, were awarded by the National Institutes of Health’s National Heart, Lung, and Blood Institute and will be led by a team of VUMC investigators.

By Nancy Humphrey
(iStock image)
September 27, 2024

Minor early changes in lungs can signal changes in progressive lung disease

The research focused on the very early stages of FPF, a serious progressive lung disease where for unknown reasons scar tissue builds up in the lungs over time.

By Nancy Humphrey
Image of the U.S., with markers that note cities where the Home Owners’ Loan Corp. conducted a city survey of impacted areas. (Source: Mapping Inequality)
September 24, 2024

Poverty rates linked to asthma in ‘redlined’ areas

Neighborhoods that were discriminated against, called ‘redlined areas,’ are known to have higher levels of air pollution from industry and vehicles, especially diesel-fueled trucks, buses and cars.

By Craig Boerner
Cosby Stone Jr., MD, MPH, examines patient Gregory Barker’s arm following Barker’s allergy test. (photo by Erin O. Smith)
September 18, 2024

Clinic marks 10th year of diagnosis and treatment of drug allergies

The clinic, celebrating its 10th year, has seen groundbreaking discoveries in personalized care and diagnosis for allergy, especially delayed drug allergy, and has advanced discoveries in the optimal process to test patients for drug allergies.

By Nancy Humphrey
August 1, 2024

VUMC adds X-ray velocimetry scanner to better detect lung dysfunction

Scanner combines fluoroscopy, a type of X-ray imaging that allows real-time visualization of body structures, with analytical software to visually document the lung’s air flow as color heat maps.
By Jill Clendening
June 13, 2024

Multicenter study identifies method of preoxygenation that prevents hypoxemia and cardiac arrest during emergency tracheal intubation

Preoxygenation is the administration of supplemental oxygen prior to the start of a procedure to increase the content of oxygen in the lung and decrease the risk of hypoxemia
By Nancy Humphrey
May 21, 2024

Acetaminophen shows promise in warding off acute respiratory distress syndrome, organ injury in patients with sepsis

Findings from NIH-supported clinical trial suggest that intravenous acetaminophen has the greatest benefit in the sickest patients.
By Nancy Humphrey
April 29, 2024

New tool helps identify babies at high risk for RSV

A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April).
By Craig Boerner
April 22, 2024

Julie Bastarache elected VP of clinical investigation society

Julie Bastarache, MD, Assistant Vice President for Clinical & Translational Scientist Development at Vanderbilt University Medical Center, has been elected vice president of the American Society for Clinical Investigation (ASCI) for 2024-2025.
By Bill Snyder
March 29, 2024

Anna Hemnes named director of the Division of Allergy, Pulmonary and Critical Care Medicine

Anna Hemnes, MD, has been named director of the Division of Allergy, Pulmonary and Critical Care Medicine, physician-in-chief of the Vanderbilt Lung Institute and director of the Center for Lung Research.
By Nancy Humphrey
February 22, 2024

NIH-funded trial to determine if immunomodulation can improve brain and cardiovascular dysfunction in Long COVID

Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first Phase III, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID.
By Nancy Humphrey
1 2 3 … 12